GWHP Sources PPE Supplies As The Delta Variant Continues to Spread

As we face COVID-19 head on, Global WholeHealth Partners is proud to continually source and supply high quality in demand PPE supplies and COVID-19 diagnostic testing kits. We know that mask wearing is required in many government buildings, airports, schools, restaurants and retail outlets and that social distancing measures are still in place, especially as the Delta variant begins to make its rounds and cases climb. 



While we are hopeful that COVID-19 cases will begin dropping as more and more vaccines are distributed and administered, we recognize the need to source and supply these products for our interested parties. Available for wholesale purchase is a great selection of PPE supplies and COVID-19 diagnostic testing kits. Visit our medical supply page online to view our current inventory and call us at 877-568-4947 to place your order.

The Delta Variant of COVID-19 is highly contagious so it is important that we do everything we can to help slow the spread of the virus. Even with the vaccines currently in distribution, it is important to remember that we can help slow the spread of COVID-19 by wearing masks in public spaces, social distancing when we can, and quarantining when we are sick. Masks wearing is required in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.

Contact GWHP Corp today to place your wholesale PPE supplies order or wholesale COVID-19 diagnostic testing kits order at 877-568-4947.


About Global WholeHealth Partners OTC (GWHP)

GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.